Identification of MYC/BCL2 double-expressers lymphomas in diffuse large B cell lymphoma patients and association with their prognostic parameters and survival rates: a single centre experience
Introduction: Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease some of which show co-expression of c-MYC and BCL2 and they are known as double expressers (DE) lymphoma. DE lymphoma has been shown to be associated with aggressive clinical course and poor outcome in comparison to those...
Main Authors: | Ahmad, Aliza, Abd Ghani, Fauzah, Jaafar, Junalina, Abdullah, Maizaton Atmadini |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
2022
|
Online Access: | http://psasir.upm.edu.my/id/eprint/99314/1/2022121912262413_MJMHS_0622.pdf |
Similar Items
-
MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients
by: Yanjie Wang, et al.
Published: (2023-09-01) -
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma
by: Mark Bosch, et al.
Published: (2018-02-01) -
Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status
by: R. K. Karakulov, et al.
Published: (2022-01-01) -
Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements
by: Gabriela Piñero-Crespo, BS, et al.
Published: (2025-01-01) -
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements
by: Ellen D. McPhail, et al.
Published: (2018-11-01)